Keratinocytes regain momentum as instigators of cutaneous inflammation
- PMID: 16443394
- DOI: 10.1016/j.molmed.2006.01.001
Keratinocytes regain momentum as instigators of cutaneous inflammation
Abstract
The primary role of skin is to serve as a protective coat and epidermal keratinocytes are responsible for this barrier function. Besides providing structural support, keratinocytes can initiate inflammatory reactions, thereby enhancing healing of skin that follows barrier perturbation. In complex diseases such as psoriasis, in which both barrier function and cutaneous inflammation are dysregulated, it is unclear whether the primary pathogenic disturbance resides in keratinocytes or in immunocytes, which are commingled in psoriatic plaques. Researchers have turned to animal models of cutaneous inflammation to gain insights into the pathogenesis of psoriasis. A recent report in which the inducible epidermal deletion of Jun proteins in adult mice triggered inflammatory skin lesions and destructive arthritis has shifted momentum towards the keratinocyte as a key instigator of cutaneous inflammation. However, because this transgenic mouse model mimics only some features of psoriasis, further studies are required before the prevailing view of psoriasis as a fundamentally immunocyte-driven disease can be replaced by the notion that keratinocytes are the primary pathogenic cells in psoriasis.
Similar articles
-
Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis.Int J Biochem Cell Biol. 2009 May;41(5):963-8. doi: 10.1016/j.biocel.2008.10.022. Epub 2008 Nov 5. Int J Biochem Cell Biol. 2009. PMID: 19027868 Review.
-
Animal models of psoriasis.Clin Dermatol. 2007 Nov-Dec;25(6):596-605. doi: 10.1016/j.clindermatol.2007.08.014. Clin Dermatol. 2007. PMID: 18021898 Review.
-
Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins.Nature. 2005 Sep 15;437(7057):369-75. doi: 10.1038/nature03963. Nature. 2005. PMID: 16163348
-
Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.Nat Med. 2005 Jan;11(1):43-9. doi: 10.1038/nm1162. Epub 2004 Dec 12. Nat Med. 2005. PMID: 15592573
-
Psoriasis: the epidermal component.Clin Dermatol. 2007 Nov-Dec;25(6):589-95. doi: 10.1016/j.clindermatol.2007.09.021. Clin Dermatol. 2007. PMID: 18021897 Review.
Cited by
-
Transcriptional regulation of epidermal barrier formation.Methods Mol Biol. 2011;763:51-71. doi: 10.1007/978-1-61779-191-8_3. Methods Mol Biol. 2011. PMID: 21874443 Free PMC article.
-
Recent Update on Immunopathogenesis of Psoriasis.Indian J Dermatol. 2022 Jul-Aug;67(4):360-373. doi: 10.4103/ijd.ijd_569_22. Indian J Dermatol. 2022. PMID: 36578729 Free PMC article.
-
IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin.J Immunol. 2014 Jun 15;192(12):6053-61. doi: 10.4049/jimmunol.1301481. Epub 2014 May 14. J Immunol. 2014. PMID: 24829417 Free PMC article.
-
Microarray patches enable the development of skin-targeted vaccines against COVID-19.Adv Drug Deliv Rev. 2021 Apr;171:164-186. doi: 10.1016/j.addr.2021.01.022. Epub 2021 Feb 2. Adv Drug Deliv Rev. 2021. PMID: 33539853 Free PMC article. Review.
-
Promising Strategies of Colloidal Drug Delivery-Based Approaches in Psoriasis Management.Pharmaceutics. 2021 Nov 22;13(11):1978. doi: 10.3390/pharmaceutics13111978. Pharmaceutics. 2021. PMID: 34834393 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous